Glen Eagle Advisors, LLC Viatris Inc Transaction History
Glen Eagle Advisors, LLC
- $604 Billion
- Q1 2025
A detailed history of Glen Eagle Advisors, LLC transactions in Viatris Inc stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 613 shares of VTRS stock, worth $5,265. This represents 0.0% of its overall portfolio holdings.
Number of Shares
613
Previous 1,031
40.54%
Holding current value
$5,265
Previous $12.8 Million
58.41%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding VTRS
# of Institutions
1,135Shares Held
953MCall Options Held
4.15MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA145MShares$1.24 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$796 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD74.5MShares$640 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az64.9MShares$558 Million3.35% of portfolio
-
State Street Corp Boston, MA61.5MShares$528 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $10.4B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...